After Long Wait, Aβ Oligomer Detangler Is Poised for Phase 2
Alzforum,
10 Nov 2023 While the trials, tribulations, and successes of Aβ immunotherapy were commanding Alzheimerologists' rapt attention…
10 Nov 2023 While the trials, tribulations, and successes of Aβ immunotherapy were commanding Alzheimerologists' rapt attention…
20 May 2022 In the brains of people with Alzheimer’s disease, toxic oligomers and protofibrils of Aβ are thought to spark a…
Scientists from Germany's Jülich Research Centre are reporting successful results from the first phase of human clinical…
The Alzheimer drug candidate PRI-002 developed at Forschungszentrum Jülich has successfully completed Phase I of clinical…